← Back to Search

AVEIR Remote Care System Non-Significant Risk Study

N/A

Waitlist Available

Research Sponsored by Abbott Medical Devices

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the expected duration of each subject's participation is approximately 30 minutes for an in-clinic visit to complete two transmissions and thereafter an optional at-home transmission (expected duration 10-15 minutes)

Awards & highlights

No Placebo-Only Group

Summary

The goal of the study is to understand the performance of the AVEIR Remote Care System in an initial patient cohort which will inform the ability to offer a remote follow-up solution to all patients implanted with Aveir LP devices.

Eligible Conditions

Slow Heart Rate
Arrhythmia
Cardiac Pacemaker

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the expected duration of each subject's participation is approximately 30 minutes for an in-clinic visit to complete two transmissions and thereafter an optional at-home transmission (expected duration 10-15 minutes)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the expected duration of each subject's participation is approximately 30 minutes for an in-clinic visit to complete two transmissions and thereafter an optional at-home transmission (expected duration 10-15 minutes)

This trial's timeline: 3 weeks for screening, Varies for treatment, and the expected duration of each subject's participation is approximately 30 minutes for an in-clinic visit to complete two transmissions and thereafter an optional at-home transmission (expected duration 10-15 minutes) for reporting.